• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用地高辛特异性抗体Fab片段逆转重度地高辛中毒

Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies.

作者信息

Smith T W, Haber E, Yeatman L, Butler V P

出版信息

N Engl J Med. 1976 Apr 8;294(15):797-800. doi: 10.1056/NEJM197604082941501.

DOI:10.1056/NEJM197604082941501
PMID:943040
Abstract

Purified Fab fragments of ovine digoxin-specific antibodies reversed severe digoxin intoxication in a patient who had taken 22.5 mg of the drug with suicidal intent. Atrioventricular block with extreme bradycardia was temporarily managed by pacing, but progressive, intractable hyperkalemia (serum potassium of 8.7 meq per liter) with increasing pacing threshold and progressive intraventricular conduction delay was controlled only after infusion of 1100 mg of Fab. Sinus rhythm returned 10 minutes after completion of Fab infusion. Within five hours, the serum potassium concentration fell to 4.0 meq per liter. Free digoxin concentrations in serum fell sharply to undetectable levels, whereas total serum digoxin concentration concomitantly increased 12-fold. Renal excretion of digoxin bound to Fab was documented. Reversal of toxicity was not accompanied by hemodynamic instability, and antibodies to sheep Fab fragments were not detected in the patient's serum after treatment. Thus, purified digoxin-specific Fab fragments are capable of rapid reversal of advanced digoxin toxicity.

摘要

纯化的羊地高辛特异性抗体Fab片段使一名蓄意服用22.5毫克该药物的患者严重的地高辛中毒得到逆转。伴有极度心动过缓的房室传导阻滞通过起搏暂时得到处理,但仅在输注1100毫克Fab后,逐渐加重的顽固性高钾血症(血清钾8.7毫当量/升)、起搏阈值增加以及进行性室内传导延迟才得到控制。Fab输注完成10分钟后窦性心律恢复。五小时内,血清钾浓度降至4.0毫当量/升。血清中游离地高辛浓度急剧下降至无法检测的水平,而血清总地高辛浓度相应增加了12倍。记录了与Fab结合的地高辛经肾脏排泄的情况。毒性逆转过程中未出现血流动力学不稳定,治疗后患者血清中未检测到针对羊Fab片段的抗体。因此,纯化的地高辛特异性Fab片段能够迅速逆转严重的地高辛中毒。

相似文献

1
Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies.用地高辛特异性抗体Fab片段逆转重度地高辛中毒
N Engl J Med. 1976 Apr 8;294(15):797-800. doi: 10.1056/NEJM197604082941501.
2
The use of digoxin-specific Fab fragments for severe digitalis intoxication in children.地高辛特异性Fab片段在儿童严重洋地黄中毒中的应用。
N Engl J Med. 1992 Jun 25;326(26):1739-44. doi: 10.1056/NEJM199206253262604.
3
Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases.用地高辛特异性Fab抗体片段治疗危及生命的洋地黄中毒:26例经验
N Engl J Med. 1982 Nov 25;307(22):1357-62. doi: 10.1056/NEJM198211253072201.
4
[Antidigoxin Fab-fragments in suicidal digoxin poisoning. Successful treatment of recurrent ventricular fibrillation].[抗地高辛Fab片段用于自杀性地高辛中毒。成功治疗复发性心室颤动]
Dtsch Med Wochenschr. 1983 Sep 23;108(38):1437-40. doi: 10.1055/s-2008-1069764.
5
Fab fragments of digoxin-specific antibodies used to reverse ventricular fibrillation induced by digoxin ingestion in a child.地高辛特异性抗体的Fab片段用于逆转一名儿童因摄入地高辛而诱发的心室颤动。
Pediatrics. 1982 Sep;70(3):468-71.
6
Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments.特异性抗体及Fab片段对严重洋地黄毒苷中毒的逆转作用及药代动力学的改变
J Clin Invest. 1977 Dec;60(6):1303-13. doi: 10.1172/JCI108889.
7
[Digitoxin poisoning: reversing ventricular fibrillation with Fab fragments of anti-digoxin antibody].[洋地黄毒苷中毒:用抗洋地黄抗体Fab片段逆转心室颤动]
Nouv Presse Med. 1982 Dec 25;11(52):3827-30.
8
Beneficial effect of digoxin-specific Fab antibody fragments in oleander intoxication.地高辛特异性Fab抗体片段在夹竹桃中毒中的有益作用。
Arch Intern Med. 1995 Oct 23;155(19):2121-5.
9
Treatment of 63 severely digitalis-toxic patients with digoxin-specific antibody fragments.用地高辛特异性抗体片段治疗63例严重洋地黄中毒患者。
J Am Coll Cardiol. 1985 May;5(5 Suppl A):118A-123A. doi: 10.1016/s0735-1097(85)80471-x.
10
Immunogenicity and kinetics of distribution and elimination of sheep digoxin-specific IgG and Fab fragments in the rabbit and baboon.绵羊地高辛特异性IgG和Fab片段在兔和狒狒体内的免疫原性、分布动力学及消除情况
Clin Exp Immunol. 1979 Jun;36(3):384-96.

引用本文的文献

1
Balancing Act: Digoxin Antidote Supply and Demand in New South Wales, Australia.平衡之举:澳大利亚新南威尔士州地高辛解毒剂的供需情况
Emerg Med Australas. 2025 Jun;37(3):e70082. doi: 10.1111/1742-6723.70082.
2
Improving the Therapeutic Selectivity of Trastuzumab Deruxtecan Using 8C2 Fab Fragments.使用8C2 Fab片段提高曲妥珠单抗德卢替康的治疗选择性
AAPS J. 2025 Jun 4;27(4):106. doi: 10.1208/s12248-025-01087-w.
3
Antidote use for cardiac arrest or hemodynamic instability due to cardiac glycoside poisoning: A narrative review.用于治疗洋地黄中毒所致心脏骤停或血流动力学不稳定的解毒剂:一项叙述性综述。
Resusc Plus. 2024 Jun 21;19:100690. doi: 10.1016/j.resplu.2024.100690. eCollection 2024 Sep.
4
Digoxin-specific antibodies: a novel dosing strategy.地高辛特异性抗体:一种新型给药策略。
Neth Heart J. 2024 Feb;32(2):70-73. doi: 10.1007/s12471-023-01814-y. Epub 2023 Oct 20.
5
Antibody-Drug Conjugates: A Review of Approved Drugs and Their Clinical Level of Evidence.抗体药物偶联物:已批准药物及其临床证据水平综述
Cancers (Basel). 2023 Jul 30;15(15):3886. doi: 10.3390/cancers15153886.
6
Persistent Cardioactive Glycosides Intoxication Related to Gastric Phytobezoar of Oleander Leaves.与夹竹桃叶胃植物性结块相关的持续性强心苷中毒
Eur J Case Rep Intern Med. 2023 Jul 29;10(8):003978. doi: 10.12890/2023_003978. eCollection 2023.
7
Mechanisms of ADC Toxicity and Strategies to Increase ADC Tolerability.ADC毒性机制及提高ADC耐受性的策略。
Cancers (Basel). 2023 Jan 24;15(3):713. doi: 10.3390/cancers15030713.
8
Payload-Binding Fab Fragments Increase the Therapeutic Index of MMAE Antibody-Drug Conjugates.载药结合 Fab 片段提高 MMAE 抗体药物偶联物的治疗指数。
Mol Cancer Ther. 2023 Apr 3;22(4):459-470. doi: 10.1158/1535-7163.MCT-22-0440.
9
Half-Life Extension and Biodistribution Modulation of Biotherapeutics via Red Blood Cell Hitch-Hiking with Novel Anti-Band 3 Single-Domain Antibodies.通过新型抗带 3 单域抗体的红细胞搭便车延长生物治疗半衰期和调节生物分布。
Int J Mol Sci. 2022 Dec 28;24(1):475. doi: 10.3390/ijms24010475.
10
Adverse Events Associated with Use of Digoxin Immune Fab Reported to the US Food and Drug Administration Adverse Event Reporting System, 1986-2019.1986年至2019年期间向美国食品药品监督管理局不良事件报告系统报告的与使用地高辛免疫Fab相关的不良事件
Drugs Real World Outcomes. 2021 Jun;8(2):253-262. doi: 10.1007/s40801-021-00242-x. Epub 2021 Mar 15.